Oxair’s Oxygen System Has the Right Chemistry at Medlab
Oxair, a leading manufacturer of gas process systems, will be demonstrating its cost-saving alternative to conventional oxygen cylinders at this year’s Medlab Asia – Pacific exhibition in Singapore from April 3-5.
Healthcare professionals are being urged to attend Stand 09 at the Suntec Exhibition & Convention Centre for a vital insight into the company’s Medical Oxygen Pressure Swing Adsorption (PSA) automated equipment and nitrogen systems which can eliminate the inconvenience and cost of shipping in conventional supply methods.
Hospitals and health facilities are dependent on safe and consistent delivery of the highest quality oxygen for patients. Oxair’s engineers at the show will be explaining the more cost-effective, secure and independent source for producing this life-saving gas without the need for traditional gas cylinders.
Its PSA units are already supplying huge cost savings and convenience for many hospitals in the Asia-Pacific region. In areas’ prone to extreme weather events such as hurricanes and typhoons, Oxair’s PSA units come into their own as they provide independence from outsourcing oxygen and nitrogen, crucial to maintaining supplies.
Traditional canisters with 1800 PSI are unsanitary and can be very dangerous inside hospital premises, especially when being moved from room to room. Oxair’s Oxygen Generator can be engineered to integrate with any existing system, or designed from scratch. It reduces manpower handling cylinders, saves room space and is immediately available at the patient’s bedside.
High purity oxygen is essential for the health and safety of patients and staff alike – the Oxair system delivers constant oxygen of 95% purity through PSA filtration. PSA is a unique process that separates oxygen from compressed air. The gas is then conditioned and filtered before being stored in a buffer tank to be used directly by the end user on demand.
Oxair’s units have already been installed in the Philippines, Tonga, Indonesia – as well as India and Africa – to provide a reliable and sustainable supply of oxygen, compared to the expense of shipping in traditional cylinders. The PSA system has helped deliver an increased level of good quality healthcare to patients in these regions.
David Cheeseman of Oxair, said: “We are delighted to be attending Medlab – it is the ideal platform for us to demonstrate the peace of mind our systems can bring to healthcare managers by offering quick payback, greater flexibility, reliability and security of supply, especially crucial to medical facilities in remote locations.”
PSA is recognised as the most popular methods used for production of oxygen gas. Oxair’s technology future proofs hospitals against further regulatory requirements. It is suitable for small to medium-sized Hospitals.